Reactive immunization has emerged as a new tool for the study of biological catalysis. A powerful application resulted in catalytic antibodies that use an enamine mechanism akin to that used by the class I aldolases. With regard to the evolution of enzyme mechanisms, we investigated the utility of an enamine pathway for the allylic rearrangement exemplified by ⌬ 5 -3-ketosteroid isomerase (KSI; EC 5.3.3.1). Our aldolase antibodies were found to catalyze the isomerization of both steroid model compounds and steroids. The kinetic and chemical studies showed that the antibodies afforded rate accelerations up to a factor of 10 4 by means of an enamine mechanism in which imine formation was the rate-determining step. In light of our observations and the enzyme studies by other workers, we suggest that an enamine pathway could have been an early, viable KSI mechanism. Although this pathway is amenable to optimization for increased catalytic power, it appears that certain factors precluded its evolution in known KSI enzymes.Many chemical reactions can proceed by alternative mechanisms. Hence, if more than one energetically accessible pathway is available for a particular transformation, it might be reasonable to expect that enzymes exist that operate via each distinct route. Yet with few exceptions, most notably the aldolases (1), Nature has apparently chosen to select and refine one approach for the conversion of a given substrate to product. One plausible explanation is that chemistry, and not specificity, has been the most challenging problem to solve during the course of enzyme evolution (2, 3). Once a clear chemical solution is found, subtle active-site modifications then occur that improve specificity and efficiency.The process of reactive immunization allows the evolution in real time of antibody catalysts with defined mechanisms (4, 5). Hence, it is possible to test whether a chemical pathway other than one found in Nature is feasible within a protein framework and how this new pathway compares with that optimized by natural selection. In fact, this approach was used to procure monoclonal antibodies (mAbs) that catalyze the aldol reaction using a lysine-mediated enamine mechanism central to the class I aldolase enzymes (5). The mechanism of these catalysts contrasts with the class II aldolases, which invoke metal ion-general base components.The ⌬ 5 -3-ketosteroid isomerase (KSI; EC 5.3.3